IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Wii Balance Board in Dizziness
This study has been withdrawn prior to enrollment.
(The study never started since it did not receive IRB approval)
Sponsor:
Kaiser Permanente
Information provided by (Responsible Party):
Kaiser Permanente
ClinicalTrials.gov Identifier:
NCT01345422
First received: April 28, 2011
Last updated: December 7, 2015
Last verified: December 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients with dizziness presently undergo physical therapy rehabilitation. Our study will study whether Wii Balance Board made by Nintendo Inc. will be helpful in patients with dizziness. They will undergo dizziness evaluation to quantify their dizziness.
| Condition | Intervention |
|---|---|
| Dizziness | Other: Wii Balance Board |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Supportive Care |
| Official Title: | A Pilot Study to Assess the Usefulness of the Wii Balance Board for Dizziness |
Resource links provided by NLM:
Further study details as provided by Kaiser Permanente:
| Enrollment: | 0 |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Wii Balance Board
Wii Balance Board Training
|
Other: Wii Balance Board
Participant will undergo Nintendo Wii Balance Board training for two months , five days a week for 30 minutes
|
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Abnormal posturography exam
Exclusion Criteria:
- Pregnant Women and children
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01345422
Please refer to this study by its ClinicalTrials.gov identifier: NCT01345422
Sponsors and Collaborators
Kaiser Permanente
Investigators
| Principal Investigator: | David Cheng, MD | Southern California Permanente Medical Group |
More Information
| Responsible Party: | Kaiser Permanente |
| ClinicalTrials.gov Identifier: | NCT01345422 History of Changes |
| Other Study ID Numbers: |
HNS1 |
| Study First Received: | April 28, 2011 |
| Last Updated: | December 7, 2015 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Plan Description: | this study did not receive IRB approval |
Additional relevant MeSH terms:
|
Dizziness Vertigo Sensation Disorders Neurologic Manifestations Nervous System Diseases |
Signs and Symptoms Vestibular Diseases Labyrinth Diseases Ear Diseases Otorhinolaryngologic Diseases |
ClinicalTrials.gov processed this record on September 19, 2017